Oral corticosteroid sparing with omalizumab in severe allergic (IgE-mediated) asthma patients

By Siergiejko Zenon   ŚŚwiebocka Ewa   Smith Nicola   Peckitt Clare   Leo Jo   Peachey Guy   Maykut Robert  

Current Medical Research and Opinion, Vol. 27, Iss. 11, 2011-11 ,pp. : 2223-2228

Informa Healthcare

Access to resources Recommend Favorite

Modeling the effects of omalizumab over 5 years among patients with moderate-to-severe persistent allergic asthma

By Grossman H.L.   Schlender Amory   Alperin Peter   Stanley Elizabeth L.   Zhang Jie  

Current Medical Research and Opinion, Vol. 26, Iss. 12, 2010-12 ,pp. : 2779-2793

Informa Healthcare

Access to resources Recommend Favorite

Anti-IgE Therapy with Omalizumab Decreases Endothelin-1 in Exhaled Breath Condensate of Patients with Severe Persistent Allergic Asthma

By  

Respiration, Vol. 80, Iss. 6, 2010-06 ,pp. : 534-542

Karger

Access to resources Recommend Favorite

Omalizumab Attenuates Airway Inflammation and Interleukin-5 Production by Mononuclear Cells in Patients with Severe Allergic Asthma

By  

International Archives of Allergy and Immunology, Vol. 161, Iss. 2, 2013-05 ,pp. : 107-117

Karger

Access to resources Recommend Favorite

RANTES in Exhaled Breath Condensate of Patients with Severe Persistent Allergic Asthma during Omalizumab Therapy

By  

International Archives of Allergy and Immunology, Vol. 154, Iss. 1, 2010-07 ,pp. : 25-32

Karger

Access to resources Recommend Favorite